Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:936-941
Published online before print January 15, 2009, doi: 10.1161/STROKEAHA.108.527713
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/936    most recent
STROKEAHA.108.527713v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, L.
Right arrow Articles by Chopp, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, L.
Right arrow Articles by Chopp, M.
Related Collections
Right arrow Embolic stroke
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2009;40:936.)
© 2009 American Heart Association, Inc.


Original Contributions

MRI Identification of White Matter Reorganization Enhanced by Erythropoietin Treatment in a Rat Model of Focal Ischemia

Lian Li, PhD; Quan Jiang, PhD; Guangliang Ding, PhD; Li Zhang, MD; Zheng Gang Zhang, PhD, MD; Qingjiang Li, MS; Swayamprava Panda, MS; Alissa Kapke, MS; Mei Lu, PhD; James R. Ewing, PhD Michael Chopp, PhD

From the Departments of Neurology (L.L., Q.J., G.D., L.Z., Z.G.Z., Q.L., S.P., J.R.E., M.C.) and Biostatistics and Research Epidemiology (A.K., M.L.), Henry Ford Hospital, Detroit, Mich; and the Department of Physics (M.C.), Oakland University, Rochester, Mich.

Correspondence to Michael Chopp, PhD, Henry Ford Hospital, Neurology Department, E&R 3056, 2799 West Grand Boulevard, Detroit, MI 48202. E-mail chopp{at}neuro.hfh.edu

Background and Purpose— The objectives of the present study were to: (1) noninvasively identify white matter reorganization and monitor its progress within 6 weeks after the onset of stroke; and (2) quantitatively investigate the effect of recombinant human erythropoietin treatment on this structural change using in vivo measurement of diffusion anisotropy.

Methods— Male Wistar rats were subjected to middle cerebral artery occlusion and treated with recombinant human erythropoietin intraperitoneally at a dose of 5000 U/kg of body weight (n=11) or the same volume of saline (n=7) daily for 7 days starting 24 hours after middle cerebral artery occlusion. MRI measurements of T2- and diffusion-weighted images and cerebral blood flow were performed and neurological severity score was assessed at 1 day and weekly for 6 weeks after middle cerebral artery occlusion. Luxol fast blue and Bielschowsky staining were used to demonstrate myelin and axons, respectively.

Results— White matter reorganization occurred along the ischemic lesion boundary after stroke. The region of white matter reorganization seen on the tissue slice coincided with the elevated area on the fractional anisotropy map, which can be accurately identified. The increase in elevated fractional anisotropy pixels corresponded with progress of white matter reorganization and was associated with improvement of neurological function. Treatment with recombinant human erythropoietin after stroke significantly enhanced white matter reorganization, restored local cerebral blood flow, and expedited functional recovery.

Conclusions— White matter reorganization can be detected by fractional anisotropy. Elevated fractional anisotropy pixels may be a good MRI index to stage white matter remodeling and predict functional outcome.


Key Words: erythropoietin • focal ischemia • fractional anisotropy • rat • white matter reorganization